Stifel Upgrades Editas Medicine (EDIT) to Buy, 'Difficult To Justify Current Valuation'

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/25/2026

1. NVDA
2. SPY
3. AAPL
4. XPEV
5. VEEV
6. DKS
7. USO
8. BMO
9. AMD
10. MU

Go back to Stifel Upgrades Editas Medicine (EDIT) to Buy, 'Difficult To Justify Current Valuation'
(NASDAQ: EDIT) Delayed: 3.23 +0.23 (7.67%)
Previous Close $3.00    52 Week High $43.99 
Open $3.05    52 Week Low $12.43 
Day High $3.33    P/E N/A 
Day Low $3.05    EPS $0.00 
Volume 3,326,855